drugset / Trial / NCT02365935

4 Versus 6 Courses of Adjuvant Chemotherapy in LACC Patients Previously Treated With NACT Plus Radical Surgery

NCT02365935

Completed 215 enrolled Campus-Bio-Medico University
RandomizedParallel-groupOpen-labelTreatment

Summary

The investigators primary outcome was to evaluate the effectiveness in term of Overall Survival (OS) and disease free interval (DFI) of two different platinum-based chemotherapic regimen (3 and 6 cycles) for treatment of Locally Advanced Cervical Cancer (LACC) (IB2-IIB) previously treated with Neoadjuvant Chemotherapy Plus Radical Surgery (NACT+RS). The secondary outcome was to evaluate and compare safety, in term of toxicity profile, of the two treatment options.

Timeline

Start
2007-02
Primary completion
2013-01
Completion
2014-09

Drugs

EvaluationDrugModalityDoseRoute
Subject Cisplatin Other / unclassified 100 mg/m2
Subject Paclitaxel Small molecule 175 mg/m2

Indications